MktsMarkets

Coherus Oncology, Inc.
NASDAQ: CHRSKey statistics
CHRS News
Stories mentioning CHRS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 3,814 | 4,045 | 3,721 | 3,395 | 2,653 | 2,750 | 2,729 | 1,809 |
| Gross Profit | (3,814) | (4,045) | (3,721) | (3,395) | (2,653) | (2,750) | (2,729) | (1,809) |
| Operating Expenses | ||||||||
| Research & Development | 21,543 | 30,974 | 27,252 | 26,306 | 24,356 | 20,759 | 22,052 | 20,598 |
| Sales General & Admin | 23,104 | 23,609 | 24,931 | 26,039 | 26,025 | 29,608 | 28,127 | 27,515 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (36,151) | (45,880) | (44,333) | (45,486) | (45,435) | (45,384) | (46,856) | (39,626) |
| Interest Income | ||||||||
| Interest Expense | 2,186 | 2,249 | 2,325 | 2,277 | 2,150 | 727.00 | 2,827 | 4,062 |
| Other Expense | 1,402 | 1,782 | 2,141 | 2,901 | 187.00 | 1,203 | 2,084 | 1,467 |
| Pretax Income | (36,935) | (46,347) | (44,517) | (44,862) | (47,398) | (44,908) | (47,599) | (54,851) |
| Tax Provision | ||||||||
| Net Income (Loss) | (38,327) | (37,643) | (35,531) | 297,767 | (56,569) | (50,696) | (10,751) | (12,921) |
| Earnings Per Share (Basic) | (0.28) | (0.32) | (0.31) | 2.57 | (0.49) | (0.44) | (0.09) | (0.11) |
| Earnings Per Share (Diluted) | (0.28) | (0.32) | (0.31) | 2.57 | (0.49) | (0.44) | (0.09) | (0.11) |
| Weighted Average Shares Outstanding (Basic) | 136,398 | 117,143 | 116,229 | 116,078 | 115,858 | 114,554 | 115,210 | 114,820 |
| Weighted Average Shares Outstanding (Diluted) | 136,398 | 117,143 | 116,229 | 116,078 | 115,858 | 114,554 | 115,210 | 114,820 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CHRS
Coherus Oncology, Inc. (NASDAQ: CHRS) is a stock listed on the Nasdaq Stock Market under the ticker symbol CHRS. It last traded at $0.5800 (Nov 11, 2026, 4:00 PM ET), down 9.1% on the day. That gives Coherus Oncology a market capitalisation of $99.0M.
Over the past 52 weeks CHRS has traded between $0.6000 and $2.62.
For the quarter ended Mar 31, 2026 it reported a net loss of $38.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$38.3M |
| Dec 31, 2025 | — | -$37.6M |
| Sep 30, 2025 | — | -$35.5M |
| Jun 30, 2025 | — | $297.8M |
From Coherus Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…